Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial
produce registration-enabling data.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 CAD | 0.00% |
|
-1.42% | -22.35% |
1st Jan change | Capi. | |
---|---|---|
-22.35% | 77.13M | |
+34.46% | 52.85B | |
-6.87% | 38.87B | |
+34.86% | 38.24B | |
-11.12% | 26.79B | |
+12.48% | 26.16B | |
-19.74% | 19.9B | |
+38.99% | 13.18B | |
+31.15% | 12.24B | |
-3.30% | 11.79B |